Clinical Trials Logo

Clinical Trial Summary

This is a retrospectively-controlled clinical trial that will examine the rate of positive UTI cases among pediatrics entered into the Emergency Department and whose urine is withdrawn using the PedSCath Pediatric Sampling Catheter. The rate of postive UTI will be compared against the control population, whose urine withdrawal would have been performed with Standard of Care devices.


Clinical Trial Description

This will be a multi-center, retrospective-controlled, clinical trial. Anonymized retrospective data from two clinical sites, NewYork-Presbyterian Queens and Weill Cornell Medical College, from 2016 and 2018 will be used to define the control subject population, who were assessed for urinary tract infection (UTI) based on a urine sample taken according to Standard of Care (SoC). Subjects entering the emergency department (ED) generally require that a urine specimen is obtained and tested to determine whether there is an active infection in the bladder. Emergency department personnel will confirm the possibility of UTI based on symptoms and inform the parents/guardians of the potential for study participation using the PedSCath. The physician will assess the subject based on Inclusion and Exclusion criteria, including non-toilet training and an upper age limit of 3 years. If determined that the subject meets inclusion/exclusion criteria, the physician will inform the parents/guardians of the subject about the study and request informed consent if the parents/guardians wish their child to participate. Following the granting of Informed Consent, subjects will be enrolled in the study within the treatment arm and a urine sample of 2-3 ml will be taken via the PedSCath. All study assessments, from enrollment through urine sample collection, will occur over a single visit to the ED. Per standard of care, any treatment following the diagnosis will be performed by hospital staff based on physician assessment. Up to 3 run-in subjects per PedSCath user will be treated with PedSCath to allow PedSCath users to become familiar with PedSCath mechanism. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04763967
Study type Observational
Source Big Blue Biotech, Inc.
Contact
Status Terminated
Phase
Start date August 27, 2021
Completion date February 2, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05066854 - INterest of the Negative Predictive Value of Integrons in Choosing a Narrow-spectrum Empirical anTibiotic Treatment vs Usual Empirical Antibiotic Treatment for Urinary Tract infectionS in the PEDiatric Emergency Department N/A
Recruiting NCT04278404 - Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Recruiting NCT04654507 - Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children Phase 3
Completed NCT03263845 - Evaluation of Pain in Urinary Collections in Pediatric Emergencies in Children Who Have Not Acquired Cleanliness N/A
Completed NCT06109688 - Effect of Lactoferrin Supplementation on Urinary Tract Infections in Infants. Phase 3
Recruiting NCT04608851 - Preventing Urinary Tract Infections With E. Coli Nissle: Phase 4
Recruiting NCT03825874 - Research of the Consequences on the Digestive Tract Following the Proposed Treatments for a Urinary Infection in Children
Withdrawn NCT06273098 - School-Based Bladder Health Intervention N/A
Recruiting NCT03221504 - 7-day Compared With 10-day Antibiotic Treatment for Febrile Urinary Tract Infections in Children N/A
Recruiting NCT05819229 - Oral Antibiotics Alone in Children Aged 4 Weeks to 2 Months With a Urinary Tract Infection
Completed NCT04066621 - PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT) Phase 4